申请人:AYERST, MCKENNA AND HARRISON INC.
公开号:EP0059596A1
公开(公告)日:1982-09-08
Herein disclosed are N-naphthoylglycine derivatives having aldose reductase inhibiting activity. The derivatives are useful for treating diabetic complications. The derivatives are of the formula
(where R' is hydrogen, lower alkyl, lower alkenyl or phenylmethyl, R2 is hydrogen or lower alkyl and R3, R4 and R5 are hydrogen or specified substituents) and therapeutically acceptable salts of the compounds wherein R2 is hydrogen. Certain intermediate amidoacids useful in the preparation of the above mentioned derivatives also have aldose reductive inhibiting effects.
本文披露了具有醛糖还原酶抑制活性的N-萘甘氨酸衍生物。这些衍生物可用于治疗糖尿病并发症。这些衍生物的化学式为(其中R'为氢、低碳基、低烯基或苯甲基,R2为氢或低碳基,R3、R4和R5为氢或指定的取代基),以及化合物的治疗上可接受的盐,其中R2为氢。在制备上述衍生物的过程中,某些中间的酰胺酸也具有醛糖还原抑制作用。